Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors (Q36643696)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2013
edit
Language Label Description Also known as
English
Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
scientific article published on January 2013

    Statements

    Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors (English)
    Robert H Vonderheide
    Jennifer M Burg
    Jennifer A Trosko
    Dongguang Li
    M Naveed Shaik
    Anthony W Tolcher
    Omid Hamid
    1 January 2013
    e23033

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit